01.Patient Engagement
London-based European HealthTech & MedTech M&A
Operators first. Bankers second.
Nelson Advisors is a specialist M&A and strategic advisory firm connecting European healthcare technology businesses with buyers, investors and partners across Europe and North America.
Founded by entrepreneurs who have built and exited HealthTech companies, we combine firsthand operating experience with institutional transaction expertise.
//About Nelson
We know the business behind the deal.
Successful HealthTech transactions require more than financial analysis. They require an understanding of the technology, the customers, the market and the people who have built the business.
We bring that perspective to every engagement. We work with founders, boards, shareholders and acquirers to identify the right strategic path, connect with the right counterparties and execute with conviction.
Build
Develop commercial strategies, enter new markets and establish the foundations for sustainable growth.
Buy
Identify, evaluate and acquire healthcare technology businesses that advance strategic objectives.
Partner
Create strategic relationships that open markets, accelerate distribution and unlock new opportunities.
Sell
Position businesses for successful exits, manage competitive M&A processes and deliver shareholder outcomes.
The right advice. At the moments that matter.
01.Grow
Growth & Partnerships
Evaluate strategic opportunities, establish commercial relationships and pursue the next stage of growth.
02.Transact
Mergers & Acquisitions
Run disciplined buy-side and sell-side processes, from initial positioning through negotiation and completion.
03.Advise
Board & Shareholder Advisory
Help founders, investors and boards navigate valuation, capital structure, strategic alternatives and transaction timing.
//Transatlantic Connectivity
A European focus. Transatlantic reach.
Headquartered in London, Nelson operates at the intersection of European healthcare innovation and North American strategic capital.
Europe
North America
Founders & management
Boards & shareholders
VC & growth investors
Strategic acquirers
Private equity
Corporate investors
London
Europe
Founders
Boards
Investors
London
Strategics
Private equity
Corporates
North America
European businesses → International buyers and capital
For European founders and shareholders, we provide access to a wider universe of potential acquirers, partners and investors.
North American acquirers → European assets and opportunities
For US and Canadian corporates, private equity firms and investors, we help identify, evaluate and execute acquisitions and strategic partnerships across Europe.
One sector. Two sides of the Atlantic.
A shared ambition to create value
// Growth & Partnerships
The right next step is not always a sale.
For some businesses, the greatest opportunity lies in entering a new market. For others, it is a strategic partnership, an acquisition or a change in commercial direction.
We help founders, management teams and boards understand their options, choose a course of action and turn strategy into execution.
Growth & Go-to-Market
- Commercial positioning
- New product launches
- Customer acquisition strategy
- Routes to market
International Expansion
- UK market entry
- European expansion
- North American entry
- Local expertise and relationships
Strategic Partnerships
- Distribution agreements
- Commercial alliances
- Joint ventures
- Strategic investment
Corporate Development
- Acquisition strategy
- Consolidation opportunities
- Strategic alternatives
- Long-term shareholder planning
Strategic Alternatives
We help founders, boards and shareholders decide whether to build, buy, partner, raise capital or sell.
- Build
- Buy
- Partner
- Raise Capital
- Sell
//Operator Heritage
We’ve lived the decisions we advise on.
Our founding partners have built, funded, scaled and exited four HealthTech businesses across patient engagement, medical device cybersecurity, metabolic health and consumer healthcare.
We understand the realities of building a business, raising capital, managing shareholders and negotiating an exit because we have experienced them ourselves. That perspective informs everything we do, from how we position a business for sale to how we evaluate a prospective acquisition.
4
HealthTech businesses built and exited
15+
Years of healthcare technology experience
EU + NA
Experience spanning European and North American markets
//M&A and Shareholder Advisory
Deep sector knowledge. Disciplined transaction execution.
A successful transaction begins well before a buyer receives a teaser. It requires the right positioning, a credible equity story, a carefully selected universe of counterparties and disciplined execution.
Nelson combines specialist healthcare technology expertise with institutional banking experience and direct partner involvement.
M&A Advisory
- Sell-Side Advisory
- Buy-Side Advisory
- Corporate Divestitures
- Technology & Asset Sales
- Strategic Acquisitions
Partnerships & Investments
- Strategic Partnerships
- Joint Ventures
- Strategic Investment
- Investor Positioning
- Corporate Development
Board & Shareholder Advisory
- Strategic Alternatives
- Valuation & Transaction Strategy
- Acquisition Strategy
- Capital Structure
- Board Advisory
Our focusEuropean healthcare technology businesses in the lower and middle market, typically $25 million to $250 million in enterprise value.
Selected transactions. Tangible outcomes.
Our experience spans completed transactions and strategic advisory mandates across Digital Health, Healthcare AI, MedTech, healthcare software and data-driven healthcare businesses.
Explore Selected Experience →02.Healthcare AI
Sale to a private equity-backed electronic patient record platform.
03.Digital Health
Sale of a digital healthcare business to a private equity portfolio company.
04.Genomics & Health Data
Strategic sale of a healthcare data technology business.
05.Medication Management
Buy-side acquisition advisory supporting a European company’s UK market entry.
06.Board & Shareholder
Strategic repositioning and transaction planning for a healthcare technology company.
Paul and Lloyd worked very closely with myself and my CFO to deliver the sale of my business to a Private Equity portfolio company. Knowing we had such capable and committed M&A advisors beside us gave me a great deal of confidence and reassurance.
“Nelson Advisors supported us with our sale to a leading Private Equity backed EPR company in Q1 2026. Lloyd and Paul’s industry knowledge and expertise is unrivalled.”
“They helped us source a range of potential acquisitions to complement our UK market entry and growth strategy.”
// Sector Expertise
One sector. Many business models.
Healthcare technology does not operate as a single market. A clinical AI platform, a medical device manufacturer and a digital therapeutics business face different commercial, regulatory and competitive realities. Understanding those differences matters when assessing value, identifying potential buyers and executing transactions.
Our exclusive focus on healthcare technology allows us to connect specialist knowledge with a broader view of industry consolidation and strategic opportunity.
MedTech/Digital Health/Healthcare AI/Healthcare IT/Patient Engagement/Health Data/Healthcare Cybersecurity/Consumer HealthTech/Metabolic Health
Exclusive focus
One sector
Exclusive focusOne sector
// The Nelson Network
The right counterparties change the outcome.
Access matters. Relevance matters more.
We maintain relationships across the healthcare technology ecosystem, bringing together the businesses, investors and decision-makers whose strategic interests intersect. Whether identifying a buyer, evaluating an acquisition or establishing a commercial partnership, our focus is on finding the right fit and creating a credible path to execution.
Founders & Management
Boards & Chairs
Strategic Acquirers
Private Equity
Health Systems & Industry Leaders
Venture Capital
Founders & Management
Boards & Chairs
Strategic Acquirers
Private Equity
Venture Capital
Health Systems & Industry
// Meet the Founders
Founders and dealmakers. On your side of the table.
Nelson was established by Lloyd Price and Paul Hemings, bringing together complementary backgrounds in healthcare technology entrepreneurship, corporate development and institutional investment banking.
Lloyd Price & Paul HemingsFounding Partners at
Nelson Advisors
Founder track record
Patient Engagement
Founded Zesty and led it through to acquisition by Induction Healthcare Group PLC (FTSE:INHC) in 2020.
Metabolic Health
Co-founded Neutrally, intercepting chronic lifestyle disease with data-led habit change, through to exit.
Medical Device Cybersecurity
Built, scaled and exited a HealthTech business securing connected medical devices.
Institutional M&A
Senior investment banking roles at Credit Suisse and investment roles at Invesco, across the US, UK, Europe and Asia.
Corporate Development
Senior business and corporate development roles at Yahoo! Europe, Kelkoo and Badoo.
Lloyd Price
Partner & Co-Founder
Lloyd has more than 12 years of healthcare technology entrepreneurship experience, including founding Zesty and leading the business through its acquisition by Induction Healthcare Group PLC in 2020. His background spans commercial strategy, business development, digital health and corporate development, including senior roles at Yahoo! Europe, Kelkoo and Badoo.
He is a Health Executive in Residence at UCL Global Business School for Health and remains active across the UK healthcare technology ecosystem.
Paul Hemings
Partner & Co-Founder
Paul combines more than a decade of international M&A and capital-raising experience with firsthand entrepreneurial experience, having founded and exited two businesses.
His background includes senior investment banking roles at Credit Suisse and investment roles at Invesco, alongside board advisory and company-building experience, most recently in metabolic HealthTech.
Supporting team
The founding partners are supported by professionals with backgrounds spanning leading investment banks, venture capital, healthcare technology and life sciences, bringing financial, commercial and scientific perspectives to client engagements.
// Insights
Perspectives from inside the market.
Healthcare technology is changing rapidly. Consolidation, new technologies, shifting investor priorities and evolving healthcare delivery models are creating new strategic opportunities.
Our research and commentary draw on sector knowledge, transaction activity and conversations across the healthcare technology ecosystem.
Nelson Advisors invited to speak at the Telehealth Canada 2027 conference
Invited to Nervecentre’s ‘First Single EPR for Primary and Secondary Care’ NHS event
Invited to ‘Designing the Future of Health’ at the Amsterdam UMC AI Innovation Center
//Contact
Whether you are evaluating an unsolicited approach, planning an acquisition, exploring a strategic partnership or considering a future exit, the right conversation can help clarify your options.
Speak directly with our founding partners about your business and what comes next.
Considering your next move?
Our Email
Our Address
Hale House, 76-78 Portland Place,
London W1B 1NT, UK
Our Focus
London | European HealthTech & MedTech M&A